5 firms await regulator’s nod to make Remdesivir

Despite rapidly rising Covid-19 deaths and an approval to use Remdesivir for treatment of severe cases, Indian patients are still waiting for the drug to be available in the country as companies are awaiting marketing approval from the Drugs Controller General of India (DCGI).